- Wockhardt stock soars up to 16% as US FDA clears novel antibiotic Zaynich Moneycontrol.com
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics market The Economic Times
- Wockhardt share price jumps 19% after securing US FDA approval for Zaynich antibiotic drug; stock up 60% in one month Upstox
- Wockhardt novel antibiotic Zaynich wins marketing approval in India ETPharma.com
- Wockhardt soars 19%, zooms 75% in 1 month; what’s driving pharma stock? Business Standard